Doctors found a nurse’s brain bleed with help from AI

AI system

System

Apparently Viz.ai.

Editor’s note. In a separate interview, the surgeon names Viz.ai and describes an unnamed ICU nurse whose circumstances match Knichel’s hospital story. He does not explicitly connect her name to the product (references 1–3).

Model

The detector for brain bleeding is not separately named. [1] [2] [3] [4]

Release

The sources do not identify the installed release. [1] [2] [3] [4]

Provider

Viz.ai, inferred from the surgeon’s separate interview.

Role

Not assessed

Configuration

Software analyzed brain images and alerted the treating team before its review, according to the surgeon. [1] [2] [4]

Inputs and outputs

Not assessed

Autonomy

Not assessed

Workflow

Software detected bleeding in brain images and alerted clinicians. The treating team investigated and treated the aneurysm. [1] [2] [3]

Human oversight

Not assessed

Relation to AI

AI flagged the bleeding and notified the stroke team, according to her treating surgeon. Clinicians treated the aneurysm. Viz.ai is an inferred identification from his separate interview. The sources do not isolate the software’s effect on survival. [1] [2] [3]

AI contribution

The surgeon reported that software detected the bleeding and alerted the stroke team. Clinicians treated the aneurysm. The sources do not separately measure the software’s effect on survival. [1] [2] [3]

Benefits

Outcome identifiers: Not assessed
Benefit: Julie Knichel’s doctors received an alert after software, apparently Viz.ai, detected her brain bleed. [1] [2] [3]
Category: Improved Physical Health
Status: Reported benefit
Beneficiary groups: People.
Beneficiaries: Not assessed
Reach: Not assessed
Distribution and access: Not assessed
Duration: Not assessed
Expected?: Yes
Costs and harms: Not assessed

Measurement

Studies: Not assessed
Study design: Not assessed
Measurement: Not assessed
Setting and sample: Not assessed
Measures: Not assessed
Comparison: Not assessed
Results: Not assessed
Additional value from AI: Not assessed
Limitations: Not assessed
Denominators: Not assessed
Materials for replication: Not assessed

Money

Kind of value: Not assessed
Amount: Not assessed
Currency and prices: Not assessed
Period and unit: Not assessed
Realization: Not assessed
Recipients and payers: Not assessed
Gross or net: Not assessed
Included costs: Not assessed
Comparison: Not assessed
Method: Not assessed
Return and payback: Not assessed

People and places

Participants: Baptist Health’s Marcus Neuroscience Institute treated Knichel. Viz.ai probably supplied the detection software. [1] [2] [3]
Jurisdictions: Knichel received care in Boca Raton, Florida, United States. Both Baptist Health and the inferred provider, Viz.ai, are based in the United States. [1] [2] [5]
Ownership and control: Not assessed
Dependencies: Not assessed
Cross-border connections: Not assessed
Geopolitical implications: Not assessed

Follow-up

Conditions for replication: Prompt clinical review and access to aneurysm treatment.
Replication attempts: Not assessed
Later findings: Not assessed
Availability: Not assessed
Institutional decision: Not assessed
Grounds: Not assessed
Action and result: Not assessed
Success criterion: Not assessed

Evidence

Source numbers: AIBD-0582-source-0001–0005 [1] [2] [3] [4] [5]
Citations: Numbered references below. [1] [2] [3] [4] [5]
Language: Not assessed
Source relationships: Operator, Independent, Developer [1] [2] [3] [4] [5]
Original evidence: Baptist Health, CBS12, and The Coastal Star interview Knichel and her surgeon. NeurologyLive separately interviews the surgeon about Viz.ai. These accounts support the treatment history but do not independently measure the software’s contribution. [1] [2] [3] [4] [5]
Access and versions: The hospital’s patient story and the surgeon’s interviews describe detection and treatment. They provide no scan-specific processing record or comparison of the software with manual review. [1] [2] [3] [4] [5]
Supported findings: Not assessed
Evidence links: Not assessed
Evidence strength: Not assessed
Missing evidence: Not assessed

Grades

Assessed benefits: People.
Depth: People: 5.
Reasons: People: Knichel survived a life-threatening hemorrhage and resumed her work and activities.
Observed or intended: Reported benefit
Rubric: Not assessed
Assessor and date: Not assessed
Alternative assessments: Not assessed
Fill: Independently reported [1] [2] [3] [4]

Entry details

Kind: Not assessed
Related entries: Not assessed
Field: Stroke care. Emergency patients with brain hemorrhage.
Purpose: Detect brain hemorrhage and alert clinicians.
Dates: Observed: 2 February 2024. Updated: 25 October 2026. [1] [2] [3] [5]
Stage: Not assessed
Version: SHA-256: 2e3e3df90466…

References

Other identifiers: Not assessed
Category mappings: Not assessed
Brief: Not assessed
Revisions: 14 revisions. Latest: 25 October 2026. [1] [2] [3] [5]

Sources

Report Deployer

Adrienne Sylver, Baptist Health, November 25, 2024.

Original patient and treating-team interviews describe the brain bleed, scan review, coiling, three-week admission and return to work. Unique stroke services; Colleagues who care.

Treating institution's account. The accompanying video is part of the same publication, not corroboration.
News report Deployer

Brian Snelling and Felipe De Los Rios. “Incorporating AI Into Stroke Triage,” NeurologyLive, October 22, 2025. Original video, 2:29–2:36 and 5:03–5:36; edited transcript, Snelling’s responses.

Snelling names Viz.ai as a hospital system and later recounts an unnamed nurse’s case that matches Knichel’s circumstances. Original video 2:29–2:36, 5:03–5:36. The edited transcript omits the pointer to the earlier press release. Access copy

Original clinician testimony. The product attribution and matching of the unnamed patient remain inferences; the video is less explicit than the edited transcript.
News report Independent author

Jan Engoren. “Health & Harmony: Fast action, expert surgeon empower nurse’s recovery from stroke,” The Coastal Star, April 29, 2025. Paragraphs describing February 2024 treatment, subarachnoid hemorrhage, and recovery.

Patient and clinician interviews establish February 2024, subarachnoid hemorrhage, treatment, and return to work. Paragraph beginning “Knichel came under Snelling’s care in February 2024”; treatment and recovery paragraphs.

Original reporting corroborates the patient outcome and chronology, not the AI product or its separate effect.
News report Independent author

Kara Duffy. “From caregiver to cared for: How an ICU nurse’s training saved her own life.” CBS12/WPEC, October 29, 2024.

Earlier original interviews name Knichel, date the episode to February 2024, and quote Snelling’s account of AI detecting the bleed before clinicians. Opening patient account, Snelling’s first response, and the video caption.

Separate reporting from the same patient and treating surgeon. It establishes an earlier public account but supplies no brand identification, clinical record, or independent measurement of the AI contribution.
Report Developer

Viz.ai. “Viz.ai Trust Center Privacy Notice.” Section 14, “Viz.ai Head Office.” Undated.

Establishes Viz.ai’s U.S. headquarters. The attribution of Viz.ai to Knichel remains inferred. Section 14, “Viz.ai Head Office”: U.S. headquarters and San Francisco address.

Original developer statement about corporate geography. It does not identify the software used for this patient or independently corroborate her clinical outcome.